Processing
Cannabis based solutions
Portocanna is a medical cannabis processor working to create the largest European symbiotic ecosystem of medical cannabis. From our EU-GMP pharmaceutical facility strategically located in Portugal, our large-scale operations support the needs of growers and serve thousands of patients through our distribution partners.
Portocanna specializes in the processing link of the value chain. By investing in complementary capabilities—namely, pharmaceutical operations, biotechnology capabilities, and supply chain management processes—we work with our partners to bring the highest quality pharma-grade products to patients across Europe.
Symbiosis is the most intelligent form of life
The Medical Cannabis industry developed from local markets that faced heavy regulation. This reality created vertically integrated, centralized businesses that focus on a Seed-to Sale strategy. Today, as demand increases and this industry earns growing recognition, we believe that it is now critical to maximize efficiency gains in every link in the value chain.
By creating a large symbiotic network of specialized growers, distributors, and innovators in Europe, we will speed the evolution of the industry and bring patients improved access to the highest quality cannabis-derived products.
Join the hive
For Growers
Reduce your operational risks
For Distributors
Deliver reliability and product diversity to your patients
For Innovators
Connect with us. Grow and develop through our network
PRODUCT
+ Diversity
+ Delivery Methods
+ IP Access
RISK MITIGATION
+ Quality Assurance
+ Procurement Network
+ Handling
ECONOMICALLY
+ SCALE
– RISK
ASSETS
Focusing on the processing link of the value chain, we invested in a 3,000sqm EU-GMP certified facility in Portugal comprised of:
• Fully equipped post-harvest processing room
• Dedicated quality control lab
• Certified extraction facility
• Large-scale packaging lines
• Large warehousing capacity
CAPABILITIES
With the diverse, highly specialized experiences of our team members and the symbiotic partnerships we have developed, we are building:
• Efficient operational processes
• Vast IP of strains & growers
• Strict pharma-grade SOPs
• Proprietary extraction methodologies
• Unique formulations
Our Partnerships
Complementing our network of local and international growers and distributors, we position ourselves in the the epicentrum of medical Cannabis knowledge and opportunity, creating partnerships with trusted and knowledgeable institutions and companies to share wisdom and design the sustainable future of this industry
Co-financed by:
